Identifying cell types that contribute to vascular sheathing pathology after AAV2.7m8-mediated gene transfer of an anti-VEGF gene therapy

Lumitin (conbercept) - Chengdu Kanghong Pharma

Israel Adam1; Wen Ting Zheng1; Shun-Yun cheng1; Delaney Giguere1; Mengtian Cui2; Qin Su2; Jun Xie2; Phillip Tai2; Guangping Gao2; Claudio Punzo1

Mar 26, 2025